|
Quansys Biosciences and LI-COR Biosciences have developed six kits
for infrared (IR) multiplexed ELISA arrays. These assays are central to
kinase drug discovery programs for indications including oncology, inflammation,
metabolic, cardiovascular and neurological diseases. The six Q-Plex™ kits include:
Quansys' multiplexed ELISA IR arrays are fully quantitative multiplexed ELISA-based tests where up to 16 distinct capture antibodies have been absorbed to each
well of a 96-well plate in a defined array. Using less than 30 microliters of sample, up to 80 samples can be simultaneously assayed for all 16 cytokines or chemokines in less
than two and a half hours, allowing for considerable savings of time, sample and money. The new kits are designed for use on LI-COR Odyssey® and Aerius®
infrared imaging systems.
LI-COR Biosciences is a leader in the design and manufacture of instrument systems for biotechnology, plant biology and environmental research. The company
pioneered the development of infrared fluorescence labeling and detection systems for proteomics, DNA sequencing, microsatellites and AFLP® research. The
Odyssey Infrared Imaging System is rapidly becoming the system of choice for quantitative Western Blot analysis. Frost & Sullivan named the Odyssey System
2006 North American Drug Discovery Technologies Product of the Year.
LI-COR Corporate Offices
4647 Superior Street
Lincoln, Nebraska USA 68504-0425
Phone: 402-467-3576
Web: www.licor.com
|
